New York State is a top recipient of NIH funding and is expected to lose about $880 million.

Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial ...

The rise of AI in health care presents new challenges related to the patentability and regulation of AI-driven medical ...

Keith Coursin, Vonnie Estes, Patrick Hidder, Andrew Horowitz, Julia Kurnik and Michael Yates are joining the board to help ...

Biology & Biotechnology 508-831-5543 [email protected] 60 Prescott Street (Gateway Park I) Biomedical Engineering 508-831-5447 [email protected] 60 Prescott Street (Gateway Park I) ...